thiazoles has been researched along with Hyperglycemia in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (5.75) | 18.7374 |
| 1990's | 19 (21.84) | 18.2507 |
| 2000's | 37 (42.53) | 29.6817 |
| 2010's | 20 (22.99) | 24.3611 |
| 2020's | 6 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Chi, L; Guo, X; Guo, Z; He, J; Liang, J; Wei, L; Ye, X; Zheng, Y | 1 |
| Amadou, C; Balla, V; Chafai, K; Ezenfis, J; Oumbiche, H; Penfornis, A | 1 |
| Baltaş, N; Hameed, S; Khan, KM; Özil, M; Qureshi, U; Salar, U; Saleem, F; Taha, M; Ul-Haq, Z | 1 |
| Adler, B; Bass, IR; Gallagher, EJ; Ryncarz, A; Tiersten, A; Trlica, K | 1 |
| Howell, SJ; Lee, CA; Lindstrom, SI; Tang, J; Taylor, BE; Taylor, PR; Taylor, ZRR; Zapadka, TE | 1 |
| Almodallal, Y; Cook, K; Jatoi, A; Martin, N | 1 |
| Chang, WT; Chen, ZC; Cheng, JT; Cheng, KC; Cheng, YZ; Li, Y | 1 |
| Gilbert, RE; Jin, T; Thai, K; Woo, M; Zhang, Y | 1 |
| Gudas, LJ; Jessurun, J; Melis, M; Patel, VM; Stummer, DJ; Tang, XH; Trasino, SE | 1 |
| Abbott, MJ; Ahmadian, M; Lopes, AB; Sul, HS; Tang, T; Wang, Y | 1 |
| Dai, G; Zhang, Y | 1 |
| Cho, SW; Dal Nam, K; Hahn, HG; Je Lee, W; Kim, EA; Yang, SJ; Young Choi, S | 1 |
| Ishibashi, K; Ishii, K; Ishiwata, K; Miura, Y; Oda, K | 1 |
| Asthana, S; Baker, LD; Bendlin, BB; Birdsill, AC; Christian, B; Craft, S; Hermann, BP; Johnson, SC; Jonaitis, EM; Koscik, RL; La Rue, A; Oh, J; Sager, MA; Statz, E; Willette, AA | 1 |
| Airoldi, C; Cabrita, EJ; de Almeida, RF; Dias, C; Jesus, AR; Jiménez-Barbero, J; Macedo, MP; Marcelo, F; Martins, A; Matos, AM; Nicotra, F; Rauter, AP; Ribeiro, RT; Viana, AS | 1 |
| Banerjee, S; Burris, TP; Campbell, S; Kamenecka, TM; Solt, LA | 1 |
| Gudas, LJ; Jessurun, J; Tang, XH; Trasino, SE | 1 |
| Barreira, B; Briones, AM; Callejo, M; Cogolludo, A; Cortijo, J; Duarte, J; Mondejar-Parreño, G; Moral-Sanz, J; Morales-Cano, D; Moreno, L; Pandolfi, R; Perez-Vizcaino, F; Salaices, M | 1 |
| Ebel, D; Goletz, C; Grueber, Y; Huhn, R; Preckel, B; Schlack, W; Weber, NC | 1 |
| Blasey, C; Davis, JM; Kraemer, H; Lieberman, JA; Reaven, GM; Schatzberg, AF; Sethuraman, G; Tsuang, MT | 1 |
| Borba, CP; Boxill, R; Cather, C; Copeland, PM; Evins, AE; Fan, X; Forstbauer, SI; Freudenreich, O; Goff, DC; Henderson, DC; Miley, K; Sharma, B | 1 |
| Alpert, E; Cohen, G; Eckel, J; Gruzman, A; Guichardant, M; Riahi, Y; Sasson, S; Sin-Malia, Y; Staels, B | 1 |
| Ishii, K; Mori, A; Nakahara, T; Saigo, O; Sakamoto, K | 1 |
| Elgire, RD; Mokale, SN; Sakle, N; Shinde, DB | 1 |
| Abdel-Baki, A; Dubreucq, S; Granger, B; Létourneau, G; Mahone, M | 1 |
| Gulati, V; Harding, IH; Palombo, EA | 1 |
| Grden, M; Kocbuch, K; Maciejewska, I; Pawelczyk, T; Sakowicz-Burkiewicz, M; Szutowicz, A | 1 |
| Araki, E; Furukawa, N; Kawaguchi, T; Kikukawa, Y; Ono, K; Shimomura, T; Suzushima, H; Watanabe, Y | 1 |
| Engelen, L; Schalkwijk, CG; Stehouwer, CD | 1 |
| McNeely, MJ; Yang, SH | 1 |
| Foley, JE; Gatlin, MR; Rosenstock, J; Shen, SG | 1 |
| Alamy, SS; Jarskog, LF; Lieberman, JA; Sheitman, BB; Spivak, B | 1 |
| Barnett, AH | 1 |
| Blanco, J; Robles, NR | 1 |
| Kotake, H | 1 |
| Abrahmsén, L; Alberts, P; Edling, N; Engblom, L; Forsgren, M; Klingström, G; Larsson, C; Ohman, B; Rönquist-Nii, Y | 1 |
| Davies, GF; Juurlink, BH; Roesler, WJ; Wu, L | 1 |
| Tan, MH | 1 |
| Bartlett, T; Demaine, AG; Hodgkinson, AD; Millward, BA; Oates, PJ | 1 |
| Ahn, JB; Ahn, SK; Hong, CI; Kim, BY; Lee, HW; Moon, KS; Shin, JS; Sim, TB | 1 |
| Brewer, B; Gavrilova, O; Gonzalez, FJ; Haluzik, M; Lambert, G; Matsusue, K; Reitman, ML; Ward, JM; Yim, SH | 1 |
| Viberti, GC | 1 |
| Halimi, S | 1 |
| Abrahmsen, LB; Alberts, P; Ashkzari, M; Bergqvist, E; Björkstrand, E; Edling, NH; Engblom, LO; Fiedler, M; Forsgren, M; Klingström, G; Larsson, C; Nilsson, C; Nilsson, CE; Norling, S; Ohman, B; Selen, G | 1 |
| Barringhaus, KG; Chen, M; Czarnik, AC; Hesselbacher, S; Ley, K; Nadler, J; Phillips, JW; Sanders, JM; Sarembock, IJ; Yang, Z | 1 |
| De Keyser, J; Koch, MW; Luijckx, GJ; Stewart, RE; Uyttenboogaart, M; Vroomen, PC | 1 |
| Haber, RS; Holand, A; O'Boyle, E; Weinstein, SP | 1 |
| van Haeften, TW; Wolffenbuttel, BH | 1 |
| Bailey, P; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Hayes, NS; Leibowitz, MD; Saperstein, R; Smith, RG | 1 |
| Melander, A | 1 |
| Burant, CF; Polonsky, KS; Pugh, W; Sreenan, S; Sturis, J | 1 |
| Colca, JR; Fisher, RM; Kletzein, RF; Parker, TT; Tanis, SP | 1 |
| Akanuma, Y; Fujiwara, T; Horikoshi, H; Iwamoto, K; Kadowaki, T; Mori, Y; Okuno, A; Tamemoto, H; Tobe, K; Ueki, K; Umesono, K; Yazaki, Y | 1 |
| Dietrich, A; Li, Z; McCaleb, M; Mihan, B; Sredy, J; Sullivan, D; Wrobel, J | 1 |
| Akiba, M; Hosokawa, T; Kakimoto, N; Kobayashi, H; Kumon, H; Morimitsu, Y; Nakamura, K; Osawa, T; Oya, T | 1 |
| Khandelwal, RL; Pugazhenthi, S | 1 |
| Cooper, ME; Gilbert, RE; Krum, H | 1 |
| Skyler, JS | 1 |
| Fujita, S; Fujiwara, T; Hagisawa, Y; Isobe, A; Takamura, M; Yachi, M; Yamada, E; Yanagisawa, H | 1 |
| Hirayama, R; Kurosaki, E; Nakano, R; Shibasaki, M; Shikama, H; Shimaya, A | 1 |
| Hirata, K; Ishida, T; Murao, S; Takahara, J | 1 |
| Arch, JR; Buckingham, RE; Cai, XJ; Lister, CA; Pickavance, L; Wilding, J; Williams, G; Wilson, S | 1 |
| Gonzalez, R; Grinsell, JW; Lardinois, CK; Michaels, JR; Sare, JS; Starich, GH; Swislocki, A | 1 |
| Kadowaki, T | 1 |
| Bailey, CJ | 1 |
| Stiefelhagen, P | 1 |
| Johnson, JH; McCarthy, KJ; Routh, RE; Shaw, W; Walsh, K; Welbourne, TC | 1 |
| Tooke, J | 1 |
| Buckingham, RE; Lister, CA; Smith, SA; Toseland, CD | 1 |
| Boehm, M; Crombie, DL; Davies, PJ; Depre, C; Heyman, RA; Leibowitz, MD; Liu, S; Nagy, L; Singh Ahuja, H; Tontonoz, P | 1 |
| Castro Cabezas, M; Erkelens, DW; Halkes, CJ | 1 |
| Goldstein, BJ | 1 |
| Akanuma, Y; Ezaki, O; Fukayama, M; Hori, W; Ide, T; Itai, A; Kadowaki, T; Kagechika, H; Kamon, J; Kato, S; Kimura, S; Komeda, K; Kubota, N; Miki, H; Motojima, K; Murakami, K; Nagai, R; Shudo, K; Terauchi, Y; Tobe, K; Tsuboyama-Kasaoka, N; Tsuchida, A; Waki, H; Yamauchi, N; Yamauchi, T | 1 |
| Chough, E; Daley, J; Gupta, S; Keaney, JF; Oates, P; Ruderman, NB; Tornheim, K | 1 |
| Lund, S; Pedersen, O; Vestergaard, H | 1 |
| Ardecky, RJ; Bean, JS; Bensch, WR; Bilakovics, JM; Broderick, CL; Brooks, DA; Brozinick, JT; Dana, SL; Etgen, GJ; Johnson, WT; Kauffman, RF; Liu, S; McCarthy, JR; Misener, EA; Montrose, CR; Ogilvie, KM; Oldham, BA; Paterniti, JR; Rito, CJ; Shuker, AJ; Tyhonas, JS | 1 |
| Johnson, JH; McCarthy, KJ; Routh, RE | 1 |
| Couturier, C | 1 |
| Gill, AM; Powell, JG; Sampson, BM; Yen, TT | 1 |
| Fujiwara, T; Fukami, M; Fukuda, K; Horikoshi, H; Wada, M; Yoshioka, S; Yoshioka, T | 1 |
| Clark, DA; Eggler, JF; Gibbs, EM; Goldstein, SW; Holland, GF; Hulin, B; Kreutter, DK; Krupp, MN; Stevenson, RW; Volkmann, RA | 1 |
| Ikeda, H; Shimura, Y; Sugiyama, Y | 1 |
| Clark, DA; Danbury, BH; Eggler, JF; Hall, KL; Holland, GF; Hutson, NJ; Krupp, MN; McPherson, RK; Stevenson, RW; Volkmann, RA | 1 |
| Chang, AY; Wyse, BM | 1 |
| Diani, AR; Sawada, GA; Wyse, BM | 1 |
| Pérès, G; Rigal, A | 1 |
| Königstein, RP | 1 |
15 review(s) available for thiazoles and Hyperglycemia
| Article | Year |
|---|---|
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycation End Products, Advanced; Guanidines; Humans; Hyperglycemia; Male; Pyridoxamine; Thiamine; Thiazoles; Treatment Outcome | 2013 |
Insulin-sensitizing agents--thiazolidinediones (glitazones).
Topics: Administration, Oral; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Approval; Europe; Humans; Hyperglycemia; Insulin; Insulin Resistance; Islets of Langerhans; Thiazoles; Thiazolidinediones; United Kingdom | 2002 |
[Antidiabetic agents and renal insufficiency].
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerulonephritis; Humans; Hyperglycemia; Hypoglycemic Agents; Inactivation, Metabolic; Insulin; Insulin Resistance; Kidney; Kidney Failure, Chronic; Liver; Renin-Angiotensin System; Thiazoles | 2002 |
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
[Thiazolidinediones: effect of the pioglitazone on hyperglycemia, dyslipidemia and cardiovascular risk].
Topics: Cardiovascular Diseases; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Pioglitazone; Risk Factors; Thiazoles; Thiazolidinediones | 2003 |
Rosiglitazone: potential beneficial impact on cardiovascular disease.
Topics: Albuminuria; Arteriosclerosis; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin Resistance; Obesity; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
[Therapeutic strategies for type 2 diabetes].
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hypoglycemic Agents; Metabolic Syndrome; Phenotype; Practice Guidelines as Topic; Thiazoles | 2003 |
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Insulin; Lipids; Prospective Studies; Randomized Controlled Trials as Topic; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; United Kingdom | 1995 |
Oral antidiabetic drugs: an overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Thiazoles | 1996 |
Drug administration in patients with diabetes mellitus. Safety considerations.
Topics: Acarbose; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Chromans; Diabetes Complications; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1998 |
[Hypoglycemic agents to improve insulin resistance].
Topics: Adipocytes; Animals; Cell Differentiation; Chromans; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypoglycemic Agents; Insulin Resistance; Obesity; Pioglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Potential new treatments for type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Thiazoles; Thiazolidinediones | 2000 |
The association between insulin resistance and endotheliopathy.
Topics: Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hyperglycemia; Hyperlipidemias; Hypertension; Insulin Resistance; Syndrome; Thiazoles; Vasodilation | 1999 |
Obesity and free fatty acids: double trouble.
Topics: Chylomicrons; Coronary Artery Disease; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperlipidemias; Insulin Resistance; Lipid Metabolism; Lipoproteins, VLDL; Liver; Obesity; Postprandial Period; Risk Factors; Thiazoles; Thiazolidinediones; Weight Loss | 2001 |
Current views on the mechanism of action of thiazolidinedione insulin sensitizers.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Models, Biological; Thiazoles | 1999 |
6 trial(s) available for thiazoles and Hyperglycemia
| Article | Year |
|---|---|
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2012 |
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Hyperglycemia; Lipid Metabolism; Lipoproteins, HDL; Male; Middle Aged; Olanzapine; Piperazines; Prediabetic State; Predictive Value of Tests; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weight; Chronic Disease; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperglycemia; Insulin Resistance; Male; Middle Aged; Morbidity; Olanzapine; Piperazines; Schizophrenia; Thiazoles; Time Factors | 2009 |
Combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes.
Topics: Adult; Aged; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.
Topics: Acute Disease; Aged; Aged, 80 and over; Blood Glucose; Brain Infarction; Female; Humans; Hyperglycemia; Male; Middle Aged; Neuroprotective Agents; Piperidines; Prognosis; Severity of Illness Index; Stroke; Thiazoles; Treatment Outcome | 2007 |
[On the etiology of the diabetogenic action of saluretics].
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Middle Aged; Thiazoles | 1965 |
66 other study(ies) available for thiazoles and Hyperglycemia
| Article | Year |
|---|---|
Adverse events of alpelisib: A postmarketing study of the World Health Organization pharmacovigilance database.
Topics: Adverse Drug Reaction Reporting Systems; Breast Neoplasms; Databases, Factual; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Humans; Hyperglycemia; Pharmacovigilance; Thiazoles; World Health Organization | 2022 |
An atypical alpelisib-induced hyperglycemic hyperosmolar and diabetic ketoacidosis state: A case report and critical analysis of alpelisib-induced hyperglycemia management guidelines.
Topics: Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Hyperglycemia; Thiazoles | 2022 |
Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
Topics: alpha-Amylases; alpha-Glucosidases; Antioxidants; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Kinetics; Molecular Docking Simulation; Oxidative Stress; Structure-Activity Relationship; Thiazoles | 2022 |
Novel breast cancer treatment leads to hyperglycaemia.
Topics: Aged; Antineoplastic Agents, Hormonal; Blood Glucose; Blood Glucose Self-Monitoring; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Female; Fulvestrant; Humans; Hyperglycemia; Monitoring, Ambulatory; Phosphoinositide-3 Kinase Inhibitors; Prediabetic State; Thiazoles | 2020 |
RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy.
Topics: Animals; Capillaries; Cell Death; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drug Inverse Agonism; Endothelial Cells; Hyperglycemia; Inflammation; Interleukin-17; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxidative Stress; Retinal Vessels; Sulfonamides; Thiazoles | 2020 |
Alpelisib-induced hyperglycemia in older patients with breast Cancer: Qualitative findings.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hyperglycemia; Thiazoles | 2021 |
GW0742 activates peroxisome proliferator-activated receptor δ to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells.
Topics: Animals; Blotting, Western; Calcium; Cardiomegaly; Cell Line; Free Radicals; Hyperglycemia; Rats; Reactive Oxygen Species; Sulfones; Thiazoles; Thiophenes | 2018 |
SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice.
Topics: Anilides; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Hyperplasia; Insulin; Male; Mice; Sirtuin 1; Thiazoles | 2018 |
Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
Topics: Animals; Benzoates; Dietary Fats; Glucose Intolerance; Hyperglycemia; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Retinoic Acid; Retinol-Binding Proteins, Cellular; Tetrahydronaphthalenes; Thiazoles; Triglycerides; Vitamin A | 2019 |
Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells.
Topics: Animals; Blood Glucose; Cells, Cultured; Diet, High-Fat; Fatty Acids; Glucose; Glucose Intolerance; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lipase; Lipolysis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; PPAR delta; RNA, Messenger; Thiazoles | 2013 |
Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Interleukin-1beta; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; NF-kappa B; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Thiazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2014 |
Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2014 |
Insulin resistance predicts brain amyloid deposition in late middle-aged adults.
Topics: Aged; Amyloid; Aniline Compounds; Apolipoproteins E; Body Mass Index; Brain; Female; Humans; Hyperglycemia; Imaging, Three-Dimensional; Insulin Resistance; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles | 2015 |
Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzothiazoles; Diabetes Mellitus, Experimental; Drug Design; Epitopes; Genista; Genistein; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Magnetic Resonance Spectroscopy; Microscopy, Atomic Force; Microscopy, Fluorescence; Oxygen; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Thiazoles | 2014 |
ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.
Topics: Animals; Autoantibodies; Cytokines; Diabetes Mellitus, Type 1; Female; Forkhead Transcription Factors; Gene Expression Regulation; Hyperglycemia; Insulin; Mice; Mice, Inbred NOD; Nuclear Receptor Subfamily 1, Group F, Member 1; Nuclear Receptor Subfamily 1, Group F, Member 3; Sulfonamides; Th17 Cells; Thiazoles | 2015 |
Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Topics: Animals; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diet, High-Fat; Drugs, Investigational; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Lipid Peroxidation; Liver; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pancreas; Receptors, Retinoic Acid; Thiazoles | 2016 |
Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries.
Topics: Animals; Coronary Vessels; Cyclic AMP; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; KCNQ1 Potassium Channel; Male; PPAR delta; PPAR-beta; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Wistar; Reactive Oxygen Species; Thiazoles; Vasodilation | 2016 |
Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases.
Topics: Anesthetics; Anesthetics, Inhalation; Animals; Blood Glucose; Blood Pressure; Blotting, Western; Desflurane; Electrocardiography; Gene Expression Regulation, Enzymologic; Heart Rate; Hyperglycemia; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles | 2008 |
The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta.
Topics: Aldehydes; Animals; Aorta; Calreticulin; Cattle; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Humans; Hyperglycemia; Lipid Peroxidation; Polymerase Chain Reaction; PPAR delta; Rabbits; RNA; RNA, Messenger; Thiazoles | 2010 |
Hyperglycemia impairs acetylcholine-induced vasodilation of retinal arterioles through polyol pathway-independent mechanisms in rats.
Topics: Acetylcholine; Animals; Arterioles; Diabetes Mellitus, Experimental; Hyperglycemia; L-Iditol 2-Dehydrogenase; Male; Phenylacetates; Rats; Rats, Wistar; Retinal Vessels; Signal Transduction; Thiazoles; Vasodilation | 2010 |
Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives.
Topics: Animals; Dietary Fats; Fibric Acids; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Propionates; Rats; Rats, Sprague-Dawley; Thiazoles | 2011 |
Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
Topics: Adult; Antipsychotic Agents; Humans; Hyperglycemia; Male; Osmolar Concentration; Piperazines; Risperidone; Schizophrenia, Paranoid; Thiazoles | 2011 |
Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia.
Topics: alpha-Amylases; Antioxidants; Australia; Benzothiazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Ferric Compounds; Flavonoids; Glycoside Hydrolase Inhibitors; Hyperglycemia; India; Magnoliopsida; Medicine, Ayurvedic; Oxidative Stress; Phenols; Phytotherapy; Picrates; Plant Extracts; Plants, Medicinal; Sulfonic Acids; Thiazoles | 2012 |
High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: involvement of P2X7 receptor.
Topics: Adenosine Triphosphate; Antibody Formation; B-Lymphocytes; Cells, Cultured; Diabetes Complications; Female; Glucose; Humans; Hyperglycemia; Immunity, Humoral; Immunoglobulin M; Infections; Male; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Staphylococcus aureus; Thiazoles | 2013 |
Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus.
Topics: Antineoplastic Agents; Benzamides; Blood Glucose; Dasatinib; Diabetes Mellitus, Type 2; Drug Resistance, Neoplasm; Humans; Hyperglycemia; Hypoglycemic Agents; Imatinib Mesylate; Insulin; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2012 |
Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
Topics: Antipsychotic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Fever; Humans; Hyperglycemia; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Pancreatitis; Piperazines; Psychotic Disorders; Rhabdomyolysis; Thiazoles | 2002 |
Ziprasidone alternative for olanzapine-induced hyperglycemia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Male; Olanzapine; Piperazines; Pirenzepine; Schizophrenia, Paranoid; Thiazoles; Treatment Outcome | 2002 |
Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Base Sequence; Blood Glucose; DNA Primers; Enzyme Inhibitors; Hydroxysteroid Dehydrogenases; Hyperglycemia; Liver; Male; Mice; Phosphoenolpyruvate Carboxykinase (GTP); Piperazines; Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Thiazoles | 2002 |
Regulation of the glyoxalase pathway in human brain microvascular endothelium: effects of troglitazone and tertiary butylhydroperoxide.
Topics: Animals; Brain; Cells, Cultured; Cerebrovascular Circulation; Chromans; Dose-Response Relationship, Drug; Endothelium, Vascular; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glycation End Products, Advanced; Hepatocytes; Humans; Hyperglycemia; Hypoglycemic Agents; Lactoylglutathione Lyase; Pyruvaldehyde; Rats; tert-Butylhydroperoxide; Thiazoles; Thiazolidinediones; Thiolester Hydrolases; Troglitazone; Up-Regulation | 2002 |
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy.
Topics: Adult; Aged; Aldehyde Reductase; Antioxidants; Benzothiazoles; Blood Glucose; Catalase; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Female; Gene Expression; Genetic Predisposition to Disease; Glutathione Peroxidase; Humans; Hyperglycemia; Leukocytes, Mononuclear; Male; Middle Aged; Phthalazines; Polymorphism, Genetic; RNA; RNA, Messenger; Superoxide Dismutase; Thiazoles | 2003 |
Synthesis and antihyperglycemic activity of erythrose, ribose and substituted pyrrolidine containing thiazolidinedione derivatives.
Topics: Animals; Cells, Cultured; Hepatocytes; Hyperglycemia; Hypoglycemic Agents; Male; Muscle Cells; Pyrrolidines; Rats; Rats, Sprague-Dawley; Ribose; Tetroses; Thiazoles; Thiazolidinediones | 2003 |
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
Topics: Animals; Blood Glucose; Fatty Acids, Nonesterified; Fatty Liver; Hyperglycemia; Insulin Resistance; Leptin; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Receptors, Cytoplasmic and Nuclear; Receptors, LDL; Receptors, Leptin; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides | 2003 |
Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Glucose Clamp Technique; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Piperazines; RNA, Messenger; Sulfonamides; Thiazoles | 2003 |
Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
Topics: Animals; Blood Glucose; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Female; Homozygote; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Rosiglitazone; Thiazoles; Thiazolidinediones; Tunica Intima | 2003 |
Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle.
Topics: Animals; Benzopyrans; Blood Glucose; Deoxyglucose; Dexamethasone; Glucocorticoids; Glucose Transporter Type 4; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Isomerism; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscles; Pioglitazone; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Tritium | 1993 |
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
Topics: Animals; Blood Glucose; COS Cells; Cricetinae; Diabetes Mellitus; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; Mice; Molecular Conformation; Peptide Hydrolases; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Triglycerides | 1996 |
Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone.
Topics: Age Factors; Animals; Body Weight; Chromans; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Hyperglycemia; Insulin; Islets of Langerhans; Male; Metformin; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1996 |
Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
Topics: Animals; Dogs; Half-Life; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Pioglitazone; Rats; Thiazoles; Thiazolidinediones | 1996 |
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Topics: Adipocytes; Adipose Tissue; Animals; Apoptosis; Blood Glucose; Blotting, Northern; Body Weight; Chromans; DNA; DNA, Complementary; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Mesentery; Polymerase Chain Reaction; Proteins; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Retroperitoneal Space; RNA; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Triglycerides; Troglitazone; Tumor Necrosis Factor-alpha | 1998 |
Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
Topics: Animals; Blood Glucose; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Zucker; Sulfones; Thiazoles | 1998 |
A novel biomarker for hyperglycemia, MRX isolated from hydrolysate of glycated proteins.
Topics: Animals; Biomarkers; Cattle; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Fluorescent Dyes; Glycoproteins; Glycosylation; Hydrolysis; Hyperglycemia; Maillard Reaction; Male; Pyridinium Compounds; Rats; Thiazoles | 1998 |
Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes.
Topics: Animals; Cells, Cultured; Enzyme Activation; Glycogen Synthase; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver; Male; Phosphoprotein Phosphatases; Pioglitazone; Protein Phosphatase 1; Rats; Thiazoles; Thiazolidinediones; Time Factors | 1998 |
Targeted glycemic control in type 2 diabetes.
Topics: Aged; Algorithms; Anti-Obesity Agents; Biguanides; Blood Glucose; Blood Glucose Self-Monitoring; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1998 |
Novel oximes having 5-benzyl-2,4-thiazolidinedione as antihyperglycemic agents: synthesis and structure-activity relationship.
Topics: Animals; Blood Glucose; Drug Evaluation; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Isomerism; Mice; Mice, Inbred Strains; Oximes; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Thiazoles; Transcription Factors | 2000 |
The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Topics: 3T3 Cells; Adipose Tissue; Animals; Blood Glucose; Cell Differentiation; Chromans; Diabetes Mellitus, Type 2; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Oxadiazoles; Pioglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Weight Gain | 2000 |
Troglitazone in progesterone derivative-induced impairment of glucose tolerance.
Topics: Aged; Antineoplastic Agents, Hormonal; Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Medroxyprogesterone Acetate; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Hypothalamus; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Neuropeptides; Obesity; Orexins; Protein Precursors; Rats; Rats, Zucker; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Transcription, Genetic | 2000 |
Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat.
Topics: Animals; Area Under Curve; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Glucose; Hyperglycemia; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Male; Pioglitazone; Postprandial Period; Rats; Rats, Inbred SHR; Thiazoles; Thiazolidinediones | 2000 |
[New development in diabetes therapy. 35th Annual Meeting of the German Diabetes Society, Munich, May 5-June 3, 2000].
Topics: Chromans; Diabetes Mellitus, Type 2; Germany; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.
Topics: Animals; Basement Membrane; Body Weight; Chondroitin Sulfate Proteoglycans; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Fibrosis; Glomerular Mesangium; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Islets of Langerhans; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Topics: Aging; Animals; Cataract; Diabetes Mellitus, Type 2; Glucagon; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Pancreas; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Thirst; Time Factors | 2000 |
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Epoxy Compounds; Fatty Acids; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Leptin; Mice; Mice, Knockout; Nicotinic Acids; Obesity; Receptors, Adrenergic, beta-3; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity.
Topics: Aldehyde Reductase; Animals; Aorta; Arginine; Benzothiazoles; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; Glucose; Hyperglycemia; In Vitro Techniques; Muscle, Smooth, Vascular; Phthalazines; Pyrogallol; Rabbits; Sodium-Potassium-Exchanging ATPase; Sorbitol; Superoxide Dismutase; Superoxides; Thiazoles | 2002 |
Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism.
Topics: Adolescent; Adult; Apolipoproteins B; Body Mass Index; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mutation; Plasminogen Activator Inhibitor 1; Receptor, Insulin; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides | 2001 |
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Dose-Response Relationship, Drug; Energy Intake; Energy Metabolism; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Organic Chemicals; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.
Topics: Animals; Cells, Cultured; Chromans; Clofibrate; Collagen Type I; Extracellular Matrix Proteins; Glomerular Mesangium; Hyperglycemia; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
[Severe thiazolidine carboxylic acid poisoning in the child. One case (author's transl)].
Topics: Acidosis; Coma; Humans; Hyperglycemia; Infant; Male; Remission, Spontaneous; Seizures; Thiazoles | 1979 |
Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Female; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Thiazoles; Thiazolidinediones | 1992 |
Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
Topics: Administration, Oral; Animals; Blood Glucose; Chromans; Diabetes Mellitus; Glucagon; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Pancreas; Thiazoles; Thiazolidinediones; Troglitazone | 1991 |
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
Topics: Adipose Tissue; Animals; Benzofurans; Biological Transport, Active; Cell Line; Deoxyglucose; Hyperglycemia; Hypoglycemic Agents; Indicators and Reagents; Mice; Mice, Obese; Molecular Structure; Monosaccharide Transport Proteins; Muscles; Structure-Activity Relationship; Thiazoles | 1991 |
Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Topics: Animals; Blood Glucose; Body Weight; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Pioglitazone; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidinediones; Triglycerides | 1990 |
Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
Topics: 3-Hydroxybutyric Acid; Animals; Benzopyrans; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Glucagon; Glycerol; Hydroxybutyrates; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Kinetics; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Reference Values; Thiazoles; Thiazolidinediones; Triglycerides | 1990 |
The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Disease Models, Animal; Glycolysis; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Obese; Mitochondria; Obesity; Oxygen Consumption; Receptor, Insulin; Thiazoles; Thiazolidinediones | 1988 |
A review of the effects of ciglitazone on the pancreatic islets of obese, hyperglycemic mice.
Topics: Animals; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Obese; Obesity; Thiazoles; Thiazolidinediones | 1988 |
[Study of blood sugar in rats after administration of different quantities of thiazolidine-4-carboxylic acid].
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Carboxylic Acids; Erythrocytes; Glucose-6-Phosphatase; Glucosyltransferases; Hematocrit; Hyperglycemia; Liver; Liver Glycogen; Male; Phosphorylases; Rats; Thiazoles | 1971 |